Galectin Therapeutics Stock Price History

GALT Stock  USD 1.04  0.96  48.00%   
Below is the normalized historical share price chart for Galectin Therapeutics extending back to September 04, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Galectin Therapeutics stands at 1.04, as last reported on the 20th of December, with the highest price reaching 1.50 and the lowest price hitting 0.73 during the day.
IPO Date
9th of September 2002
200 Day MA
2.6485
50 Day MA
2.5438
Beta
0.629
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Galectin Stock, it is important to understand the factors that can impact its price. Galectin Therapeutics holds Efficiency (Sharpe) Ratio of -0.17, which attests that the entity had a -0.17% return per unit of risk over the last 3 months. Galectin Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Galectin Therapeutics' Standard Deviation of 3.75, risk adjusted performance of (0.07), and Market Risk Adjusted Performance of (0.22) to validate the risk estimate we provide.
  
At this time, Galectin Therapeutics' Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 308.2 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 14.9 M in 2024. . Price Earnings Ratio is likely to drop to -2.55 in 2024. Price Book Value Ratio is likely to gain to -1.57 in 2024. Galectin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1651

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsGALT

Estimated Market Risk

 7.03
  actual daily
62
62% of assets are less volatile

Expected Return

 -1.16
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average Galectin Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galectin Therapeutics by adding Galectin Therapeutics to a well-diversified portfolio.
Price Book
207.6975
Book Value
(1.01)
Enterprise Value
206.2 M
Enterprise Value Ebitda
(4.04)
Shares Float
43.1 M

Galectin Therapeutics Stock Price History Chart

There are several ways to analyze Galectin Stock price data. The simplest method is using a basic Galectin candlestick price chart, which shows Galectin Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 8, 20243.0
Lowest PriceDecember 20, 20241.04

Galectin Therapeutics December 20, 2024 Stock Price Synopsis

Various analyses of Galectin Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Galectin Stock. It can be used to describe the percentage change in the price of Galectin Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Galectin Stock.
Galectin Therapeutics Price Daily Balance Of Power(1.25)
Galectin Therapeutics Accumulation Distribution 4,748,490 
Galectin Therapeutics Price Action Indicator(0.55)
Galectin Therapeutics Price Rate Of Daily Change 0.52 

Galectin Therapeutics December 20, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Galectin Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Galectin Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Galectin Stock and then apply it to test your longer-term investment strategies against Galectin.

Galectin Stock Price History Data

The price series of Galectin Therapeutics for the period between Sat, Sep 21, 2024 and Fri, Dec 20, 2024 has a statistical range of 1.09 with a coefficient of variation of 10.6. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.59. The median price for the last 90 days is 2.66. The company completed 1:6 stock split on 23rd of March 2012.
OpenHighLowCloseVolume
12/20/2024 1.18  1.50  0.73  1.04  9,250,306 
12/19/2024 2.02  2.11  1.90  2.00  673,885 
12/18/2024 2.12  2.15  1.97  2.02  866,938 
12/17/2024 2.32  2.32  1.99  2.12  922,516 
12/16/2024 2.20  2.36  2.12  2.31  710,161 
12/13/2024 1.97  2.20  1.96  2.11  905,421 
12/12/2024 1.96  2.03  1.91  1.99  826,655 
12/11/2024 1.95  2.00  1.86  1.95  661,757 
12/10/2024 1.91  2.00  1.84  1.93  896,321 
12/09/2024 2.03  2.09  1.80  1.91  1,711,699 
12/06/2024 2.00  2.25  2.00  2.05  943,358 
12/05/2024 2.42  2.46  2.10  2.11  692,882 
12/04/2024 2.54  2.59  2.30  2.36  575,934 
12/03/2024 2.80  2.81  2.58  2.60  537,498 
12/02/2024 2.95  2.96  2.74  2.80  422,072 
11/29/2024 2.86  2.95  2.80  2.89  265,881 
11/27/2024 2.80  2.99  2.79  2.84  358,582 
11/26/2024 2.70  2.85  2.70  2.77  229,713 
11/25/2024 2.83  2.85  2.70  2.71  176,279 
11/22/2024 2.72  2.82  2.68  2.78  133,423 
11/21/2024 2.85  2.90  2.71  2.72  141,317 
11/20/2024 2.75  2.82  2.67  2.82  132,468 
11/19/2024 2.70  2.78  2.68  2.76  108,016 
11/18/2024 2.77  2.85  2.65  2.69  174,060 
11/15/2024 2.80  2.88  2.66  2.77  219,064 
11/14/2024 2.86  2.95  2.75  2.75  153,767 
11/13/2024 2.96  3.04  2.82  2.90  210,533 
11/12/2024 2.89  3.02  2.89  2.96  116,980 
11/11/2024 3.17  3.17  2.85  2.89  202,489 
11/08/2024 2.85  3.05  2.82  3.00  240,401 
11/07/2024 2.78  2.89  2.76  2.84  118,551 
11/06/2024 2.80  2.85  2.67  2.81  268,287 
11/05/2024 2.55  2.62  2.52  2.61  99,995 
11/04/2024 2.46  2.60  2.46  2.53  107,402 
11/01/2024 2.51  2.58  2.45  2.50  110,178 
10/31/2024 2.50  2.57  2.45  2.47  114,855 
10/30/2024 2.55  2.65  2.51  2.52  130,694 
10/29/2024 2.49  2.64  2.49  2.55  132,039 
10/28/2024 2.56  2.60  2.49  2.49  181,909 
10/25/2024 2.57  2.59  2.51  2.51  110,536 
10/24/2024 2.62  2.62  2.53  2.55  121,869 
10/23/2024 2.62  2.65  2.52  2.58  144,543 
10/22/2024 2.64  2.65  2.59  2.62  80,625 
10/21/2024 2.70  2.70  2.57  2.63  103,205 
10/18/2024 2.66  2.70  2.64  2.67  118,348 
10/17/2024 2.79  2.80  2.63  2.66  132,364 
10/16/2024 2.63  2.73  2.61  2.63  204,040 
10/15/2024 2.65  2.67  2.59  2.60  109,302 
10/14/2024 2.70  2.70  2.61  2.63  83,733 
10/11/2024 2.64  2.70  2.59  2.70  101,338 
10/10/2024 2.62  2.63  2.52  2.58  86,861 
10/09/2024 2.74  2.80  2.60  2.63  93,801 
10/08/2024 2.67  2.78  2.63  2.74  137,566 
10/07/2024 2.85  2.89  2.63  2.66  213,405 
10/04/2024 2.75  3.16  2.73  2.82  408,349 
10/03/2024 2.72  2.86  2.67  2.72  89,004 
10/02/2024 2.68  2.77  2.68  2.72  43,717 
10/01/2024 2.76  2.77  2.67  2.72  117,997 
09/30/2024 2.72  2.83  2.72  2.75  65,411 
09/27/2024 2.67  2.73  2.67  2.71  63,919 
09/26/2024 2.68  2.73  2.62  2.65  144,481 

About Galectin Therapeutics Stock history

Galectin Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Galectin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Galectin Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Galectin Therapeutics stock prices may prove useful in developing a viable investing in Galectin Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding60.2 M63.2 M
Net Loss-35 M-36.7 M

Galectin Therapeutics Quarterly Net Working Capital

3.41 Million

Galectin Therapeutics Stock Technical Analysis

Galectin Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Galectin Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Galectin Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Commodity Channel Now

   

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Galectin Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Galectin Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Galectin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Galectin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Galectin Stock Analysis

When running Galectin Therapeutics' price analysis, check to measure Galectin Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galectin Therapeutics is operating at the current time. Most of Galectin Therapeutics' value examination focuses on studying past and present price action to predict the probability of Galectin Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galectin Therapeutics' price. Additionally, you may evaluate how the addition of Galectin Therapeutics to your portfolios can decrease your overall portfolio volatility.